The GlySure continuous intravascular glucose sensor contains a fluorescent indicator chemistry, which produces a signal that is proportional to the glucose concentration in the patient's blood. The reversible nature of the glucose-fluorophore bond enables monitoring throughout the patient's length of stay with the same sensor. In clinical testing on intensive care patients the sensor has continuously monitored patient's blood glucose for over 100 hours. Click here for detailed report.
The CGM sensor is placed in intensive care patients via a central venous catheter (CVC). As central venous access is required on nearly all ICU patients, the sensor does not require any additional access lines.